Despite the numerous benefits, there are several challenges in developing nanodrugs:
- Regulatory Hurdles: The regulatory pathway for nanodrugs is complex and requires extensive safety and efficacy data. - Manufacturing: Producing nanodrugs at scale while maintaining quality and consistency is challenging. - Biocompatibility: Ensuring that nanomaterials are biocompatible and do not elicit adverse immune responses is crucial. - Cost: The development and production of nanodrugs can be expensive, which may limit their accessibility.
